Live news related to CELYAD ONCOLOGY stock (BE0974260896): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on CELYAD ONCOLOGY mainly cover M&A activity. The stock trades at €0,20 on Euronext Paris, down 4,76% at the last update. This page lists the articles published on CELYAD ONCOLOGY stock to track the share price, company announcements and any item likely to influence market perception.
Celyad Oncology published on September 23, 2026 its accounts for the first half of 2026, closed on June 30. The Belgian biotech company, now refocused…
Belgian biotechnology firm Celyad Oncology has completed a capital increase with Fortress Investment Group for €500,000, enabling the latter to become…
